EUVIMEDEUVIMED entdecken
Crossref

Cisplatin Promotes Hepatotoxicity by cGAS‐STING Mediated Innate Immune Response

Qiongyan Tao, Yimin Zhou, Genwen Chen, Jianyong Sun iD

Journal of Gastroenterology and Hepatology · 2025-05 · 40 (5) · 1283-1296

DOI: 10.1111/jgh.16926 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 07.03.2025. Verfasst von Qiongyan Tao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Cisplatin, Nucleotidyltransferases, Membrane Proteins, Immunity, Innate. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Nature Science Foundation of China, Shanghai Sailing Program, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although platinum‐based chemotherapy represented by cisplatin has been widely approved for the management of diverse cancer types, its hepatotoxicity and other adverse effects impact patient prognosis, while currently, there are few effective strategies for prevention or treatment. RNA sequencing analysis indicated that the type I interferon (IFN‐I) pathway was significantly upregulated in cisplatin‐induced liver injury (CILI) mouse model. The cGAS‐STING signaling was found to be significantly activated in vitro and CILI model in vivo. Mechanistically, cisplatin‐induced DNA damage triggered the release of double‐stranded DNA (dsDNA), which subsequently activated the cGAS‐STING pathway. The activated pathway promoted the production of IFN‐I and induced apoptosis, ultimately contributing to liver injury. Importantly, inhibition of the cGAS‐STING pathway, either by enzymatic digestion of dsDNA or by genetic knockout of cGAS, effectively attenuated IFN‐I production and liver injury in response to cisplatin. Overall, our results highlight the cGAS‐STING‐IFN‐I axis as a promising therapeutic target for preventing and treating platinum‐based drug‐induced liver damage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinNucleotidyltransferasesMembrane ProteinsImmunity, InnateChemical and Drug Induced Liver InjuryAntineoplastic AgentsAnimalsSignal TransductionInterferon Type IHumansDNA DamageMice, Inbred C57BLDisease Models, AnimalMiceApoptosisMaleMice, KnockoutCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseSTING Protein

Substanzen

CisplatinNucleotidyltransferasesMembrane ProteinsInterferon Type IAntineoplastic AgentscGAS protein, mouseCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseSting1 protein, mouseSTING Protein

Autor:innen und Institutionen

  • Department of Gastroenterology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.

ORCID-Profile: Jianyong Sun

Förderung

  • National Nature Science Foundation of China
  • Shanghai Sailing Program
  • China Postdoctoral Science Foundation
  • Outstanding Resident Clinical Postdoctoral Program of Zhongshan Hospital Affiliated to Fudan University

Zitieren

APA

Tao, Q., Zhou, Y., Chen, G., & Sun, J. (2025). Cisplatin Promotes Hepatotoxicity by cGAS‐STING Mediated Innate Immune Response. Journal of Gastroenterology and Hepatology, 40(5), 1283-1296. https://doi.org/10.1111/jgh.16926

Vancouver

Tao Q, Zhou Y, Chen G, Sun J. Cisplatin Promotes Hepatotoxicity by cGAS‐STING Mediated Innate Immune Response. Journal of Gastroenterology and Hepatology. 2025;40(5):1283-1296. doi:10.1111/jgh.16926

BibTeX
@article{Tao2025,
  author = {Tao, Qiongyan and Zhou, Yimin and Chen, Genwen and Sun, Jianyong},
  title = {Cisplatin Promotes Hepatotoxicity by cGAS‐STING Mediated Innate Immune Response},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2025},
  volume = {40},
  number = {5},
  pages = {1283--1296},
  doi = {10.1111/jgh.16926}
}
Kostenlos starten →